Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
Andrew Blumenfeld, Richard B. Lipton, Stephen D. Silberstein, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1533-1551
Open Access | Times Cited: 11

Showing 11 citing articles:

Setting higher standards for migraine prevention: A position statement of the International Headache Society
Simona Sacco, Messoud Ashina, Hans‐Christoph Diener, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access | Times Cited: 1
Integrating manual therapy into headache management: bridging the evidence gap
Roberto Tedeschi
Neurological Sciences (2025)
Closed Access
Cannabinoids in headache: helpful or harmful?
Deena E. Kuruvilla
Current Opinion in Neurology (2025)
Closed Access
Patient perceptions of barriers to effective migraine management in Aotearoa New Zealand
Blair McInnarney, Fiona Imlach, Jonathan Kennedy, et al.
Journal of Primary Health Care (2024) Vol. 16, Iss. 4, pp. 347-356
Open Access | Times Cited: 1
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group
Todd J. Schwedt, Amynah Pradhan, Michael L. Oshinsky, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 8, pp. 912-930
Open Access | Times Cited: 1
Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review
Andrew Blumenfeld, László Mechtler, Lisa Cook, et al.
Pain and Therapy (2024)
Open Access
Headache Medicine
Larry CharlestonIV
Springer eBooks (2024), pp. 135-158
Closed Access
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (TEAM) study
Gregory A. Panza, Michael L. Johnson, Deena E. Kuruvilla
Headache The Journal of Head and Face Pain (2024)
Open Access
What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle
Richard B. Lipton, Jessica Ailani, Andrew Blumenfeld
Neurology and Therapy (2024) Vol. 13, Iss. 6, pp. 1535-1540
Open Access
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures
Stewart J. Tepper, Merle L. Diamond, Joe Hirman, et al.
Journal of Neurology (2024) Vol. 272, Iss. 1
Open Access
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety
Maria Tiziana Corasaniti, Gary W. Lawrence, Giacinto Bagetta, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Page 1

Scroll to top